Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Cash from Financing Activities (2018 - 2025)

Evolus' Cash from Financing Activities history spans 8 years, with the latest figure at $77000.0 for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 105.86% year-over-year to $77000.0; the TTM value through Dec 2025 reached $17.3 million, down 63.43%, while the annual FY2025 figure was $17.3 million, 63.43% down from the prior year.
  • Cash from Financing Activities reached $77000.0 in Q4 2025 per EOLS's latest filing, up from -$1.8 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $93.8 million in Q2 2021 to a low of -$76.8 million in Q1 2021.
  • Average Cash from Financing Activities over 5 years is $8.9 million, with a median of -$804000.0 recorded in 2022.
  • The largest YoY upside for Cash from Financing Activities was 29889.21% in 2021 against a maximum downside of 6853.94% in 2021.
  • A 5-year view of Cash from Financing Activities shows it stood at $47.9 million in 2021, then tumbled by 103.17% to -$1.5 million in 2022, then skyrocketed by 1651.58% to $23.5 million in 2023, then tumbled by 105.58% to -$1.3 million in 2024, then skyrocketed by 105.86% to $77000.0 in 2025.
  • Per Business Quant, the three most recent readings for EOLS's Cash from Financing Activities are $77000.0 (Q4 2025), -$1.8 million (Q3 2025), and $20.7 million (Q2 2025).